1199.34.02001 Boehringer Ingelheim Investigational Site

Calgary, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Fibrosis

Studies at this site

• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II — Completed